Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MAAYAN, S
Right arrow Articles by CHEN, Y M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAAYAN, S
Right arrow Articles by CHEN, Y M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Oxford University Press

other

HTLV among Israeli Intravenous Drug Abusers

S MAAYAN*, M DAN**, R MARLINK{dagger} and Y M CHEN{dagger},{ddagger}

* Department of Clinical Microbiology, Hadassah University Hospital Jerusalem, Israel
** Infectious Diseases Unit, Wolfton Hospital Holon, Israel
{dagger} Department of Cancer Biology, Harvard School of Public Health Boston, USA

{ddagger} Current address: Institute of Public Health, National Yong Ming Medical College, Taipei, Taiwan

Maayan S (Department of Clinical Microbiology, Hadassah University Hospital, Jerusalem, Israel), Dan M, Marlink R and Chen Y M. HTLV among Israeli intravenous drug abusers. International Journal of Epidemiology 1992; 21: 995–997 Since human T lymphotropic virus (HTLV) infection was recently described in Israel and other Middle Eastern countries, we have investigated the presence of HTLV type 1 and type 2 in a group of 299 intravenous (IV) drug abusers who were seen at a large methadone clinic in the Tel Aviv area in 1986–1987. We found that 1.3% were seropositive to HTLV. Further testing revealed that HTLV1 was the only HTLV serotype. In addition, no coinfection HIV1/HTLV1 and no HIV2 infection were detected. Since all HTLV seropositives were born in Middle Eastern countries, did not travel outside Israel and were not infected by HIV1 or by HTLV type 2, it is possible that the source of HTLV1 infection in that group was in an endemic reservoir of HTLV1 in Israel. The detection of HTLV1 among IV drug abusers and among other groups in Israel necessitates more extensive HTLV testing in at-risk populations.

Received 1 April 1992


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.